The following summarizes the report contents by section:
SECTION I: Market Status, Trends and Forecasts
Analysis of recent sales, competitive challenges, new products in the pipeline and forces affecting future growth. Also provides sales forecasts to 2013. Products include:
- Iodinated agents for CT, angiography, fluoroscopy and nonvascular studies. Doses sold, market trends and product sales by application.
- MRI contrast media sales for neuro, body imaging and MR angiography. Doses sold and growth trends. Prospects for new targeted agents for specialized applications.
- Ultrasound contrast agents for cardiology ventricular and perfusion studies. Recent sales growth and market prospects. Progress of clinical studies to expand product indications.
SECTION II: Analysis of Procedure Volume
- Historic and forecast growth of procedures in CT, MR, angiography and ultrasound.
- Distribution of procedures by application in neuro, abdominal, chest, spine and body.
SECTION III: Contrast Media Products and Technology
- Technical principles and functional characteristics of contrast agents.
- Prospects and opportunities in new technologies and probable market impact.
SECTION IV: Clinical Applications
- Discussion of clinical applications for different types of contrast agents.
- Analysis of product characteristics, performance benefits and trade-offs.
SECTION V: Current Research and Emerging Technologies
- Description of products in development within each major market segment including CT, MRI and ultrasound contrast agents.
- Description of new technologies for contrast agents, such as biomarkers for targeted imaging, microencapsulated agents for molecular imaging, enhanced radiology ultrasound, tumor seeking microbubbles and targeted nanoparticles for atherosclerosis.
SECTION VI: Industry Analysis
- Analysis of current suppliers with individual product sales and market shares in 2006
- Market distribution, pricing strategies and new products in the pipeline.
- Discussion of marketing goals, product plans, corporate partnerships and new ventures.
SECTION VII: End-User Analysis
- Analysis of end-user groups and comparative requirements for medical imaging.
- Procedure mix and product utilization in hospitals and clinics.
SECTION VIII: Company Profiles
- Background information on companies in the field and review of recent performance.
- Discussion of each company's market activities and management strategies.
|
Back to Top
BTSI260.doc
-OR-
BTSI260.pdf
Send
this page to a friend